Retatrutide (a triple GIP/GLP-1/glucagon receptor agonist), survodutide, mazdutide, and CagriSema represent the next generation of anti-obesity compounds that may offer even greater efficacy or better tolerability profiles
This can be particularly helpful for individuals who have a deficiency and need to boost their levels rapidly
This process improves blood pressure and cholesterol levels, which lower heart disease risk
Many of our patients receive Hydroxocobalmin injections approximately once every 10 - 12 weeks
A: A comprehensive evaluation including symptom assessment and blood testing determines your B12 status and identifies any absorption issues
The systematic review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO), registration number: CRD42024554513 (Available from) ( 2.2 PICOs question The primary research question addressed in this review was: What is the effectiveness of sublingual/oral administration of Vitamin B12 alone or compared to other forms of administration (e.g., intramuscular injection)?